SecBot SecBot

MNRO

MONRO, INC.
Nasdaq· Services-Automotive Repair, Services & Parking· Inc. NY· CIK 0000876427 Services
$10.48 +0.12 (+1.16%)
Nov 13 4:00 PM ET · prev $10.36
Market cap
$324.4M
Small cap
Consensus
Buy
64% Buy or better · 11 analysts
Median target
$13.50
+29% · range $12.00–40.00
1 year
−37.1%
from $16.65 · Nov 17
30 days
−24.1%
from $13.80
52-week range
$10.36–23.81
−56% from high · low Nov 12
Avg volume 20D
1.06M
shares / day
Short interest
7.14M
≈22.8% of shares · −1.5%
Days to cover
7.3
at average volume
Insider net
+$501.9K
1 buyer · 0 sellers · 12 mo
New fund stakes
0
Q3 2026 13F · 2 exits
Filing reports
8
analyzed by SecBot
SecBot read BEARISH 3 reports · 90 days
Balance 1 bearish · 0 bullish · 2 neutral oldest → newest, height = score
Avg score ·High conf. 3/3

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBULLISH

    1 insider bought $501.9K at an average $19.23. No open-market sales. Price is 46% below their cost.

  • InstitutionsBEARISH

    Q3 2026: 12 added (0 new), 22 trimmed or exited.

  • AnalystsBULLISH

    7 of 11 rate it Buy or better. Every target is above the price.

  • Short sellersSTEADY

    Short interest −1.5% to 7.14M shares. 7.3 days to cover, ≈22.8% of shares.

  • TrendDOWNTREND

    19% below its 50-day average. New closing low $10.36 on Nov 12.

Who's buying

13F· Q3 2026
0
new positions
2
exits
FundMoveSharesValue
MORGAN STANLEYADD2,052,728$28.7M
MARSHALL WACE, LLPDOUBLED771,221$10.8M
Russell Investments Group, Ltd.ADD600,149$8.4M
MONETA GROUP INVESTMENT ADVISORS LLCDOUBLED569,242$8.0M
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUNDTRIM284,500$4.0M
BNP PARIBAS FINANCIAL MARKETSDOUBLED130,836$1.8M
CITIGROUP INCDOUBLED91,625$1.3M
Nuveen, LLCTRIM89,298$1.2M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

11 analysts
Buy 64% rate it Buy or better
Strong Buy4Buy3Hold4Sell0Strong Sell0
12-month targets · 4 analysts

Price is below the lowest target. Median implies +29%.Targets as of Nov 17, 2026.

Recent actions
DateFirmActionRating
Oct 30, 2026Wells Fargo
MAINTAIN
MAINTAINEqual-Weight
Oct 23, 2026Wells Fargo
MAINTAIN
MAINTAINEqual-Weight
Jul 30, 2026Stephens & Co.
MAINTAIN
MAINTAINOverweight
Jun 11, 2026Wells Fargo
MAINTAIN
MAINTAINEqual-Weight

Insider ledger

Form 4
$501.9K
bought · 1 insider
$0
sold · 0 insiders
−45.5%
vs their $19.23 cost
DateInsiderTypeValue
Aug 11, 2026
Hyde Lindsay
Director
Aug 11, 2026
AWARD11,149 sh
Aug 11, 2026
Johnson Leah C.
Director
Aug 11, 2026
AWARD11,149 sh
Aug 11, 2026
MCCLUSKI STEPHEN C
Director
Aug 11, 2026
AWARD11,149 sh
Aug 11, 2026
Okray Thomas B
Director
Aug 11, 2026
AWARD11,149 sh
Aug 11, 2026
Woodhouse Hope B
Director
Aug 11, 2026
AWARD11,149 sh
Aug 11, 2026
SOLOMON PETER J
Director
Aug 11, 2026
AWARD11,149 sh
Aug 11, 2026
MELLOR ROBERT E
Director
Aug 11, 2026
AWARD11,149 sh
Jun 19, 2026
Mulholland Maureen
Executive VP-CLO and Secretary
Jun 19, 2026
TAX W/H393 sh

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY-$0.44-$0.83–-$0.20-503.7%$1.1B
Next FY🔒 Fresh data, subscribers only

Short side

FINRA· Oct 30, 2026
7,140,724
shares short
-1.5%
vs prior settlement
7.3
days to cover
≈22.8%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 13, 2026 SEC
Morgan Stanley filed a Schedule 13G disclosing a 6.1% passive stake in Monro, Inc. as of September 30, 2026…
SC 13G · Impact 3/10
Nov 4, 2026 SEC
Monro extended its shareholder rights plan (poison pill) by one year, from November 6, 2026 to November 1, 2027, to…
8-K · Impact 3/10
Oct 29, 2026 SEC
Monro reported Q2 fiscal 2027 results with sales down 1.8% to $283.6M and a net loss of $1.6M versus net income of…
8-K · Impact 5/10
Oct 29, 2026 Earnings result
MNRO Q2 2027 Earnings: EPS $-0.01 (-120.0% vs est)
Sep 30, 2026 Inst.
MORGAN STANLEY · ADD
2,052,728 shares ($28.7M)
Sep 30, 2026 Inst.
MARSHALL WACE, LLP · DOUBLED
771,221 shares ($10.8M)
Aug 11, 2026 Insider
Hyde Lindsay was granted 11,149 shares
Director
Aug 11, 2026 Insider
Johnson Leah C. was granted 11,149 shares
Director
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent

SecBot reports

8 filings · 2 bullish · 2 bearish · 4 neutral
All MNRO filing & press-release reports (8)